Cargando…

Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty

This is the fourth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2(nd) updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audie...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahlmann, Ralf, Lode, Hartmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186799/
https://www.ncbi.nlm.nih.gov/pubmed/32373441
http://dx.doi.org/10.3205/id000060
_version_ 1783527031962599424
author Stahlmann, Ralf
Lode, Hartmut
author_facet Stahlmann, Ralf
Lode, Hartmut
author_sort Stahlmann, Ralf
collection PubMed
description This is the fourth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2(nd) updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Safety and tolerability of antimicrobial agents will be discussed in this chapter. Toxic, allergic and biological effects can be differentiated on the basis of their pathogenesis. The question of differences in the tolerability of specific antibiotics is of particular importance. However, due to limitations of the available data, it cannot be answered for most agents with the desired accuracy. For an assessment of rare side effects, results from the postmarketing surveillance have to be used.
format Online
Article
Text
id pubmed-7186799
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-71867992020-05-05 Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty Stahlmann, Ralf Lode, Hartmut GMS Infect Dis Article This is the fourth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2(nd) updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Safety and tolerability of antimicrobial agents will be discussed in this chapter. Toxic, allergic and biological effects can be differentiated on the basis of their pathogenesis. The question of differences in the tolerability of specific antibiotics is of particular importance. However, due to limitations of the available data, it cannot be answered for most agents with the desired accuracy. For an assessment of rare side effects, results from the postmarketing surveillance have to be used. German Medical Science GMS Publishing House 2020-03-26 /pmc/articles/PMC7186799/ /pubmed/32373441 http://dx.doi.org/10.3205/id000060 Text en Copyright © 2020 Stahlmann et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Stahlmann, Ralf
Lode, Hartmut
Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title_full Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title_fullStr Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title_full_unstemmed Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title_short Calculated initial parenteral treatment of bacterial infections: Safety and tolerabilty
title_sort calculated initial parenteral treatment of bacterial infections: safety and tolerabilty
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186799/
https://www.ncbi.nlm.nih.gov/pubmed/32373441
http://dx.doi.org/10.3205/id000060
work_keys_str_mv AT stahlmannralf calculatedinitialparenteraltreatmentofbacterialinfectionssafetyandtolerabilty
AT lodehartmut calculatedinitialparenteraltreatmentofbacterialinfectionssafetyandtolerabilty